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Abstract
Background: Polymorphisms in the FK506 binding protein 5 (FKBP5) gene have been shown to influence glucocorticoid receptor 
sensitivity, stress response regulation, and depression risk in traumatized subjects, with most consistent findings reported 
for the functional variant rs1360780. In the present study, we investigated whether the FKBP5 polymorphism rs1360780 and 
lifetime history of major depression are associated with DNA methylation and FKBP5 gene expression after psychosocial stress.
Methods: A total of 116 individuals with a positive (n = 61) and negative (n = 55) lifetime history of major depression participated 
in the Trier Social Stress Test. We assessed plasma cortisol concentrations, FKBP5 mRNA expression, and CpG methylation of 
FKBP5 intron 7 in peripheral blood cells.
Results: Genotype-dependent plasma cortisol response to psychosocial stress exposure was observed in healthy controls, 
with the highest and longest-lasting cortisol increase in subjects with the TT genotype of the FKBP5 polymorphism rs1360780, 
and healthy controls carrying the T risk allele responded with a blunted FKBP5 mRNA expression after psychosocial stress. No 
genotype effects could be found in remitted depression.
Conclusions: The FKBP5 rs1360780 polymorphism is associated with plasma cortisol and FKBP5 mRNA expression after 
psychosocial stress in healthy controls but not in remitted depression. Preliminary results of the DNA methylation analysis 
suggest that epigenetic modifications could be involved.
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Introduction
The hypothalamus-pituitary-adrenocortical (HPA) axis is the 
major neuroendocrine response system that regulates the 
somatic stress reaction. Dysregulation of the HPA axis can be 
a consequence of an impaired function of the glucocorticoid 
receptors (GRs) that mediate the effects of corticosteroids 
(Holsboer, 2000; Pariante, 2004). Proper GR function is essential 
for a negative feedback regulation of the HPA axis. The HSP90 
co-chaperone FK506 binding protein 5 (FKBP5) is an important 
functional regulator in the GR complex. FKBP5 is part of the 
ultra-short intracellular negative feedback loop with GR where 
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FKBP5 reduces glucocorticoid binding affinity (Denny et al., 2000) 
and nuclear translocation of the GR (Wochnik et al., 2005) and 
thus acts as a negative regulator of the GR transcriptional activ-
ity. GR activation, in turn, leads to an increase in FKBP5 mRNA 
and protein expression, as glucocorticoids such as cortisol 
induce the expression of FKBP5 (Vermeer et  al., 2003; Binder, 
2009; Jääskeläinen et al., 2011).
Single nucleotide polymorphisms (SNPs) within the FKBP5 
gene are known to influence GR sensitivity and thus HPA axis 
regulation, which has been discussed as a key endocrine marker 
for stress-related disorders such as major depression (MD) 
(Lekman et  al., 2008; Lavebratt et  al., 2010; Zobel et  al., 2010; 
Appel et  al., 2011; Zimmermann et  al., 2011) or posttraumatic 
stress disorder (PTSD) (Binder et al., 2008; Xie et al., 2010; Mehta 
et  al., 2011). The most consistent findings have been reported 
for rs1360780, a SNP located in the second intron of the FKBP5 
gene; the T allele of this SNP forms a putative transcription start 
site (Klengel et  al., 2013). Healthy subjects carrying the T risk 
allele of this SNP show relative GR resistance as indicated by an 
escape from the dexamethasone (dex)-induced suppression of 
plasma cortisol (Binder et al., 2008; Touma et al., 2011). GR resist-
ance was also demonstrated after activation of the HPA axis 
during a psychosocial stress test (Ising et al., 2008; Buchmann 
et al., 2014). Healthy individuals with the rs1360780 TT genotype 
responded with prolonged plasma cortisol concentrations and 
more anxiety symptoms during the recovery period after the 
stress test (Ising et al., 2008).
Gene expression studies further elucidate the association 
between FKBP5 and MD. It could be shown in mice that chronic 
corticosterone treatment increases FKBP5 mRNA to a similar 
extent in hippocampus, hypothalamus, and peripheral blood 
cells, while a corresponding reduction of FKBP5 DNA methyla-
tion could be observed in the hypothalamus and blood cells (Lee 
et al., 2010). FKBP5 mRNA levels are also associated with depres-
sion outcome, as successful antidepressant treatment response 
was related to reduced FKBP5 gene expression (Cattaneo et al., 
2013). GR resistance, which is a common phenomenon in MD, 
can be detected by measuring FKBP5 mRNA levels in peripheral 
blood. Menke et al. (2012b) investigated the GR-stimulated gene 
expression in peripheral blood cells in 2 cohorts of patients 
and healthy controls. Stimulated mRNA levels of FKBP5 and 
other candidate genes could discriminate better between cases 
and controls than baseline gene expression or suppression of 
plasma cortisol by dex. The same research group found differ-
ent FKBP5 mRNA levels between acutely depressed patients and 
healthy controls, which were associated with rs1360780 (Menke 
et al., 2013).
Epigenetic modifications such as DNA methylation are 
important determinants of mRNA gene expression, as recently 
demonstrated for FKBP5. FKBP5 mRNA can be upregulated by glu-
cocorticoids (Vermeer et al., 2003; Jääskeläinen et al., 2011) but 
also by demethylation of specific regions in the FKBP5 gene (Lee 
et al., 2010; Klengel et al., 2013; Yehuda et al., 2013). Interestingly, 
genetic variations, in particular FKBP5 SNP rs1360780, also seem 
to influence how environmental exposure impacts epigenetic 
marks. Klengel et al. (2013) discovered in a sample of patients 
with PTSD that CpG methylation patterns around glucocorticoid 
response elements (GREs) in intron 7 of the FKBP5 gene are asso-
ciated with the T risk allele of rs1360780 and early childhood 
trauma, presumably due to a genotype-dependent interaction 
between the distal GREs and the transcription start site in intron 
2, which is formed by the T allele of rs1360780. This interpreta-
tion is in agreement with in vitro findings suggesting that FKBP5 
activation is majorly regulated by distal rather than proximal 
GREs (Paakinaho et al., 2010).
Thus, combining measures of HPA axis regulation with mRNA 
expression and DNA methylation will be important to elucidate 
the role of FKBP5 in stress regulation. In the present study, we 
exposed participants with a lifetime history of MD who were 
in full remission for at least 6 months, as well as healthy con-
trol subjects, to a psychosocial stress test to examine the effect 
of a previous MD and the FKBP5 SNP rs1360780 on: (1) plasma 
cortisol concentrations, (2) FKBP5 mRNA levels in peripheral 
blood cells after psychosocial stress, and (3) DNA methylation of 
intron 7 in the FKBP5 gene.
Methods
Subjects
A total of 116 subjects aged 30 to 42  years (mean(M) = 34.35, 
standard deviation (SD) = 3.43) were recruited from partici-
pants of the Early Developmental Stages of Psychopathology 
(EDSP) study. The EDSP study is a longitudinal epidemiological 
study designed to investigate the prevalence, incidence, risk 
factors, comorbidity, and course of mental disorders in a com-
munity sample of adolescents and young adults. The original 
EDSP sample was randomly drawn from the 1994 govern-
ment registries of all residents aged 14 to 24 years in Munich 
(Germany). After the baseline investigation, 3 follow-up inves-
tigations were conducted covering an overall time period of 
10 years (Wittchen et al., 1998; Lieb et al., 2000; Zimmermann 
et  al., 2011). The present study sample was selected on the 
basis of the aggregated diagnostic information of all EDSP 
assessments.
The remitted MD group included participants with a lifetime 
DSM-IV diagnosis of MD who were in full remission for at least 
6 months. Exclusion criteria were DSM-IV lifetime diagnoses of 
dysthymia, schizophrenia, substance use disorder, social pho-
bia, or the specific phobia of a blood-injection-injury type. As 
a control sample, we recruited from the same epidemiological 
cohort subjects with a negative history of any affective disorder, 
general anxiety disorder, or any other mental disorder men-
tioned within the exclusion criteria of the MD sample. Medical 
conditions known to influence HPA axis activity were also 
excluded. We further excluded subjects on current antidepres-
sant medication for the analysis (Wagner et al., 2012; Cattaneo 
et al., 2013).
For comparison reasons, mRNA data are shown from N = 14 
unstressed control subjects without a history of mental disor-
ders and aged 27 to 39 years (M = 32.93, SD = 3.77) who underwent 
repeated afternoon blood collections without participation in a 
stress test.
All subjects were Caucasians. Participants gave oral and writ-
ten consent after being informed about the study procedure. The 
study was approved by the local Ethics Committee of the Ludwig 
Maximilians University, Munich, Germany.
Diagnostic Assessment
Eligible EDSP participants were invited by letter and contacted 
by telephone. If respondents gave their consent to participate 
and matched inclusion criteria cross-checked by a brief tel-
ephone interview, they were invited for a diagnostic appoint-
ment. Diagnostic assessment was based on the computerized 
Munich version of the Composite International Diagnostic 
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Interview (M-CIDI), which allows for the standardized assess-
ment of symptoms, syndromes, and diagnoses of DSM-IV dis-
orders as well as their onset, duration, and severity (Wittchen 
and Pfister, 1997). Moreover, childhood adverse events were 
assessed with the M-CIDI. A  childhood adverse event was 
defined as separation from a parent (through death or parental 
divorce/separation) or exposure to a PTSD-qualifying trauma 
prior to the age of 13 years. Information on childhood adverse 
events was derived from the PTSD and family history section of 
the M-CIDI. The M-CIDI interview was used in the EDSP study 
in all assessments.
Trained interviewers conducted the interval version of the 
M-CIDI covering the time period between the previous assess-
ment and the current evaluation. Presence of acute depres-
sion symptoms within the last 14  days was evaluated using 
the Beck Depression Inventory II (BDI) (Hautzinger et al., 2009). 
Participants were invited for the experimental part of the study 
if they did not exceed a BDI score of 14.
Experimental Procedure
The Trier Social Stress Test (TSST) was applied during after-
noon sessions at the Max Planck Institute of Psychiatry in 
Munich, Germany. In fact, the TSST was administered twice 
during the experimental sessions; however, this analysis will 
focus on acute stress effects obtained from the first TSST. 
Study investigators and participants were not aware of the 
group assignment as an MD or healthy control according to 
the M-CIDI diagnoses.
A venous catheter was placed in the forearm vein at least 
30 minutes prior to the collection of the baseline blood sam-
ple. After baseline evaluations, the TSST protocol was started 
(Kirschbaum et al., 1993; Ising et al., 2008). The TSST is a pub-
lic speaking task involving a mock job interview and a mental 
arithmetic task. The participants were informed about the stress 
procedure and were given 10 minutes of preparation time for a 
presentation about their professional education. After that, the 
subjects were escorted to another room to give their presenta-
tion in front of a mixed-gender panel of 2 judges who are trained 
to withhold verbal and nonverbal feedback. The TSST itself 
consists of a 5-minute mock job interview and an unexpected 
5-minute mental arithmetic task. Both tasks were audio- and 
videotaped so as to increase task engagement. Blood samples 
were drawn before and subsequently after the stress procedure 
in 15-minute intervals following the TSST. During the recovery 
period, participants could choose between watching movies and 
reading newspapers.
Hormone Assessment
Plasma adrenocorticotropic hormone (ACTH) was meas-
ured using an immunoradiometric assay (cobas ECLIA, Roche 
Diagnostics, Rotkreuz, Switzerland). The detection limit for 
plasma ACTH was 1.0 pg/mL. Plasma cortisol was determined 
using a radioimmunoassay kit (CT Cortisol RIA, DRG Diagnostics, 
Marburg, Germany). The detection limit was 1.7 ng/mL.
DNA Extraction and Genotyping
Blood samples (7.5 mL) were collected in ethylenediamine-
tetraacetic acid containing tubes at baseline and DNA was 
extracted using the Puregene whole blood DNA-extraction kit 
(Gentra Systems Inc.). The FKBP5 SNP rs1360780 was genotyped 
by using real-time PCR and subsequent melting curve analysis 
performed with a Lightcycler 480 Genotyping Master (Roche 
Applied Science, Mannheim, Germany). The minor allele fre-
quency was 28%. Genotype distribution did not deviate from 
the Hardy-Weinberg equilibrium as indicated by a nonsignifi-
cant P value of the exact test (P = .110). The SNP could be suc-
cessfully genotyped in all samples (call rate = 100%).
Assessment of FKBP5 Gene Expression
Whole blood samples using PAXgene Blood RNA tubes (QIAGEN 
GmbH, Hilden, Germany) were collected at baseline as well as 
+45 and +70 minutes after the TSST. FKBP5 gene expression 
analysis was performed using fast real-time PCR with a TaqMan 
gene expression assay (Applied Biosystems Deutschland GmbH, 
Darmstadt, Germany). Gene expression was quantified in rela-
tion to the average activity of 4 housekeeping genes (glucose-
6-phosphate dehydrogenase, ß-glucuronidase, TATA box binding 
protein, phospholipase A) showing excellent concordance for all 
time points (average intraclass correlation: r = .922). The call rate 
was 100%.
DNA Methylation Analysis
DNA methylation analysis was performed by Varionostic 
GmbH (http://www.varionostic.de) using an EpiTYPER assay, 
which is based on bisulfite conversion and matrix-assisted 
laser desorption/ionization time-of-flight mass spectrom-
etry (Sequenom Inc, San Diego, CA). The region of interest 
was defined as the genomic region located in intron 7 of the 
FKBP5 gene (chr6:35,666,288-35,666,763, hg18) corresponding 
to the P1 region as defined by Klengel et al. (2013). The ampli-
con was designed with the Qiagen Assay Design Software 2.0. 
Bisulfite treatment, PCR, and post-PCR steps of the EpiTYPER 
assay were performed according to the manufacturer’s pro-
tocol. Seven CpGs are contained within the target region 
(units 1 to 7); units 5 (chr6:35,666,544), 6 (chr6:35,666,688), 
and 7 (chr6:35,666,699) could not be assessed due to tech-
nical reasons. We averaged for the statistical analysis the 
methylation of units 1 to 4 (chr6:35,666,364; chr6:35,666,416; 
chr6:35,666,466; chr6:35,666,491) covering the area of the GRE, 
which has been described to be associated with altered stress 
responsiveness (Klengel et  al., 2013). Complete methylation 
data of units 1 to 4 were available for N = 96 subjects (call 
rate = 82%).
Statistical Analysis
Demographic data were compared between groups (remitted 
MD/controls) using an independent sample t test for continu-
ous data and Pearson’s chi-square test or Fisher’s exact test for 
categorical data.
A general genotypic model with exploratory posthoc com-
parisons between genotypes was used for all genetic analyses. 
For the analysis of plasma cortisol, we applied a repeated-
measures analysis of covariance ( ANCOVA) with the between-
subject factors depression (remitted MD/controls) and FKBP5 
genotype of the SNP rs1360780 (CC/CT/TT genotype) and with 
the within-subject factor time (baseline, prestress, poststress, 
+15 minutes, +30 minutes, +45 minutes, +70 minutes). Baseline 
cortisol was added as a covariate. FKBP5 mRNA expression after 
psychosocial stress was also evaluated with a repeated-meas-
ures ANCOVA including the factors depression, FKBP5 genotype, 
and time (baseline, +45 minutes, +70 minutes). In a preliminary 
analysis, a 2-way ANCOVA was used to test the effects of the 
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factors depression and FKBP5 genotype on the DNA methylation 
rate in intron 7 of the FKBP5 gene. As covariates in the mRNA 
and DNA methylation analysis, we included gender, age, and the 
relative concentration of blood cell types (erythrocytes, lympho-
cytes, granulocytes, monocytes) of the baseline blood sample. 
Correction effects of the blood cell types on mRNA and DNA 
methylation were determined using Cohen’s f (Cohen, 1988). 
Correction effects on mRNA concentrations showed small effects 
for lymphocytes, monocytes, and granulocytes (f = .10 − .25), 
or were below the threshold of a small effect for erythrocytes 
(f < .10). Correction effects on DNA methylation were below the 
threshold of a small effect (f < .10) for all cell types.
Huynh-Feldt–corrected P-values are reported when appro-
priate. The level of significance was set to P = .05. Analyses were 
performed with PASW Statistics for Windows (Version 18.0., 
SPSS Inc. released 2009, Chicago, IL).
Results
Sociodemographic variables and study characteristics are listed 
in Table 1. Subjects with remitted depression and healthy con-
trols did not differ in age, gender, body mass index, and nico-
tine or caffeine consumption. A total of 38 participants suffered 
previously from a single episode of MD, and 23 subjects had 
recurrent MD with on average 5.61 (SD = 4.70) previous episodes. 
The mean age at onset was 20.48 years (SD = 5.51) and the last 
episode was on average 10.73  years (SD = 5.79) ago, which did 
not differ between single episode and recurrent depression. The 
mean BDI score at the test day was significantly higher in the 
depression group (M = 2.23, SD = 3.00) than in controls (M = 1.17, 
SD = 1.66, P = .019) but remained within the range of “no depres-
sion” according to the BDI manual.
Plasma Cortisol and ACTH Concentrations
The repeated-measures ANCOVA of plasma cortisol concentra-
tions, corrected for baseline cortisol concentrations, showed a 
significant effect of time (F5,545 = 23.39, P < .001), indicating a suc-
cessful stress induction by the TSST. There was a nonsignificant 
trend toward an interaction of depression × FKBP5 genotype 
(F2,109 = 2.98, P = .055). Furthermore, we found a significant inter-
action of time × depression (F5,545 = 3.16, P = .028) and an interac-
tion of time × depression × FKBP5 genotype (F10,545 = 3.66, P = .002). 
Healthy control subjects with the TT genotype at rs1360780 
showed the highest plasma cortisol concentrations in the 
recovery period following psychosocial stress (Figure 1). To dis-
entangle these interactions, we conducted pointwise compari-
sons separately for each group and found a significant FKBP5 
genotype effect in healthy controls (+15 minutes poststress, 
P = .017; +30 minutes, P = .006; +45 minutes, P = .011; +70 min-
utes, P = .015). Healthy controls with the TT genotype showed 
increased plasma cortisol concentrations after the TSST 
(Figure 1a). No genotype-dependent differences in the plasma 
cortisol response to the TSST were observed in the remitted 
MD group (Figure  1b). When comparing cortisol differences 
separately for each genotype, we found in the TT genotype 
significant group effects at +15 minutes (P = .016), +30 minutes 
(P = .015), and +45minutes poststress (P = .007) with higher cor-
tisol plasma levels in controls. Regarding plasma ACTH, there 
was a significant effect of time, indicating the efficacy of the 
stress induction (F5,545 = 26.19, P < .001). However, we did not 
observe significant depression or genotype effects for ACTH.
FKBP5 mRNA Gene Expression
Repeated-measures ANCOVA of FKBP5 mRNA revealed a sig-
nificant interaction effect of time × depression × FKBP5 geno-
type (F4,208 = 3.43, P = .010). Healthy subjects with the rs1360780 
CC genotype showed an increase of FKBP5 mRNA after stress 
exposure, whereas healthy subjects with the CT or TT genotype 
showed blunted FKBP5 mRNA levels. Again, no genotype effect 
on mRNA expression was found within the remitted MD group 
(Figure 2). Posthoc analyses separately for each group revealed 
a significant genotype effect in healthy controls +70 minutes 
(P = .015) and a nonsignificant trend +45 minutes poststress 
Table 1. Demographic and Clinical Characteristics
Total Remitted MD Healthy Controls
Pn = 116 n = 61 n = 55
Gender, n (%) n.s.a
 Female 56 (48) 29 (47) 27 (49)
 Male 60 (52) 32 (53) 28 (51)
Age (range 30–42 y), M (±SD) 34.35 (3.46) 34.65 (3.32) 34.02 (3.61) n.s.b
BMI, M (±SD) 24.35 (3.90) 23.95 (3.29) 24.79 (4.47) n.s.b
Relationship status, n (%) n.s.a
 Single 59 (51) 28 (46) 31 (56)
 Married 52 (45) 29 (48) 23 (42)
 Divorced 5 (4) 4 (6) 1 (2)
Depression history, n (%)
 Single episode MD 38 (62)
 Recurrent MD 23 (38)




BDI TSST, M (±SD) 1.73 (2.50) 2.23 (3.00) 1.17 (1.66) .019b
Abbreviations: BMI, body mass index; BDI TSST, Beck Depression Inventory score on the day of the stress experiment; M, mean; MD, major depression; n.s., not 
significant; SD, standard deviation.
a Chi-square test/Fisher’s exact test.
b Student’s t test.
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(P = .087). Healthy controls with the CC genotype showed higher 
FKBP5 mRNA levels after stress exposure than subjects carry-
ing the TT or CT genotype (Figure 2a). There were no genotype 
effects in the remitted MD group (Figure 2b). Pointwise compari-
son by FKBP5 genotype showed a significant group effect for the 
CC genotype +45 minutes (P = .049) and +70 minutes poststress 
(P = .003). Healthy subjects with the CC genotype showed higher 
FKBP5 mRNA levels than subjects with a lifetime history of MD 
and this genotype.
DNA Methylation of Intron 7 in the FKBP5 Gene
Following Klengel et al. (2013), we analyzed DNA methylation in 
intron 7 of the FKBP5 gene and evaluated differences between 
groups and FKBP5 genotype in n = 96 subjects. In this prelimi-
nary analysis, we found a significant group × genotype interac-
tion (F2,84 = 3.12, P = .049) for the mean FKBP5 DNA methylation 
in this region in intron 7.  Posthoc comparisons did not reach 
significance but suggested a nonsignificant trend toward gen-
otype-dependent CpG methylation differences among subjects 
with a lifetime history of MD (P = .096). Furthermore, there was a 
nonsignificant trend for a group effect in subjects carrying the 
TT genotype (P = .096). Subjects with the TT genotype and a life-
time history of MD had a 10% higher DNA methylation rate than 
healthy controls with the same FKBP5 genotype (Figure 3).
Discussion
To investigate the role of genetic and genomic markers of the 
stress regulator FKBP5, we performed the TSST in 116 partici-
pants from an epidemiological sample with a positive (n = 61) 
and a negative (n = 55) lifetime history of MD. Given the converg-
ing findings from previous studies, we focused on the effects of 
the intronic FKBP5 variant rs1360780, on FKBP5 mRNA expres-
sion in peripheral blood cells, and on FKBP5 intron 7 CpG meth-
ylation. Three major findings could be observed. First, we found 
a genotype-dependent plasma cortisol response to psychoso-
cial stress exposure in healthy subjects with the highest and 
longest-lasting cortisol increase in subjects with the TT geno-
type of rs1360780, whereas no genotype-dependent effects were 
detected in participants remitted from MD. Second, healthy con-
trols with the CC genotype showed an increase of FKBP5 mRNA 
following stress, whereas controls with the CT genotype or the 
TT genotype responded with a blunted FKBP5 mRNA expression 
after psychosocial stress. Again, we could not observe genotype 
effects in subjects with a lifetime history of MD. Third, a prelimi-
nary analysis of the CpG methylation around GREs in intron 7 
of the FKBP5 gene suggested depression and genotype-specific 
differences in FKBP5 DNA methylation. Our results point to an 
important role of the FKBP5 genotype and FKBP5 gene activity for 
the HPA axis response to psychosocial stress. Expanding upon 
Figure 1. Genotype-dependent (rs1360780) change of plasma cortisol levels 
corrected for baseline cortisol concentration in (a) healthy controls (n = 55) 
and (b) subjects with remitted lifetime history of major depression (MD) 
(n = 61). The figure shows estimated means with standard error bars and 
P-values from pointwise comparisons of the FKBP5 genotype effect within 
the control group.
Figure  2. Genotype-dependent (rs1360780) change of FKBP5 mRNA levels cor-
rected for baseline cortisol concentration in (a) healthy controls (n = 55) and (b) 
subjects with remitted lifetime history of major depression (MD) (n = 61). FKBP5 
mRNA in unstressed control subjects (dotted lines) is additionally included as 
a reference. The figure shows estimated means with standard error bars and 
P-values from pointwise comparisons of the FKBP5 genotype effect within the 
control group.
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previous research, we could demonstrate that these effects dis-
tinctly differ between subjects with a lifetime history of MD and 
healthy controls.
Subjects remitted from depression and healthy controls 
showed different genotype effects of FKBP5 on the plasma corti-
sol response to psychosocial stress. Healthy individuals with the 
rs1360780 TT genotype responded with increased plasma corti-
sol concentrations and a delayed cortisol peak in the recovery 
period after exposure to psychosocial stress. This genotype is 
known to be related to an impaired sensitivity of the GR as indi-
cated by an escape from the suppressive effects of dex (Binder 
et  al., 2008; Touma et  al., 2011) and to a higher vulnerability 
to stress-related disorders in traumatized subjects including 
depression (Appel et  al., 2011; Zimmermann et  al., 2011) and 
PTSD (Binder et al., 2008; Klengel et al., 2013). This finding rep-
licates our previous study using the same psychosocial stress 
test in a different sample of healthy controls (Ising et al., 2008). 
Healthy subjects with the rs1360780 TT genotype show a mark-
edly increased and prolonged cortisol response to psychosocial 
stress, presumably as a result of a reduced sensitivity of the GR, 
and thus an impaired negative feedback inhibition of the HPA 
axis, which, in turn, contributes to the reported higher vulner-
ability to stress-related disorders. No genotype effects on ACTH 
could be observed, which is in agreement with previous reports 
(eg, Ising et al., 2008), suggesting cortisol as the most sensitive 
stress hormone regarding FKBP5 effects.
FKBP5 affects the GR function by influencing the nuclear 
translocation (Wochnik et al., 2005) and binding affinity (Denny 
et al., 2000), and it is also part of an ultra-short feedback loop 
with the GR, which is an important mechanism in the restoration 
of the HPA axis after stress exposure (Binder, 2009). FKBP5 mRNA 
can be upregulated by glucocorticoids (Jääskeläinen et al., 2011); 
thus, one would expect an increase of FKBP5 mRNA following 
cortisol release after exposure to laboratory psychosocial stress. 
Indeed, oral administration of 1.5 mg of dex, a synthetic gluco-
corticoid with high affinity to the GR, resulted in a more than 
5- to 10-fold stimulation of FKBP5 expression in peripheral blood 
cells after 3 hours (Menke et al., 2013). However, in our study we 
did not observe a general induction of FKBP5 mRNA after psy-
chosocial stress. The reasons for the absence of a general FKBP5 
mRNA induction might be 2-fold: (1) oral administration of 
1.5 mg of dex results in a nonphysiologically fast and intensive 
GR stimulation, whereas GR stimulation in a psychosocial stress 
situation is gradual and moderate; (2) dex directly stimulates 
peripheral GR, whereas the stress situation in the laboratory 
activates GR indirectly in response to the stress-induced cortisol 
surge. Furthermore, GR effects are restricted to peripheral GRs 
as dex hardly passes the blood-brain barrier (Meijer et al., 1998), 
while psychosocial stress by nature is perceived and processed 
in the central nervous system. Even though we did not find a 
general FKBP5 mRNA response to psychosocial stress, we found 
an interaction between the FKBP5 genotype and depression his-
tory on FKBP5 expression. Healthy subjects with the CC geno-
type, which is associated with normal GR function (Binder et al., 
2008; Ising et al., 2008), responded with a significant induction of 
FKBP5 mRNA after psychosocial stress. Whereas the TT genotype 
seems to predispose healthy subjects to a resistant and nona-
daptive stress response regulation resulting in an increased and 
extended cortisol response, the CC genotype is associated with 
a more adaptive response pattern: the cortisol response seems 
to be situationally adequate and is accompanied by an adaptive 
upregulation of FKBP5.
To our surprise, FKBP5 genotype-related effects on plasma 
cortisol and FKBP5 mRNA response to psychosocial stress were 
observed only in healthy controls. Previous studies reported 
FKBP5 genotype-related differences on HPA axis responsiv-
ity in acutely depressed patients (Binder et  al., 2004; Menke 
et al., 2013) and healthy controls (Binder et al., 2008; Ising et al., 
2008), but, to the best of our knowledge, there are no functional 
studies on subjects with remitted depression. In our study, 
participants remitted from depression did not show a signifi-
cant upregulation of FKBP5 mRNA but presented with a regular 
cortisol response after psychosocial stress; both effects were 
independent of the FKBP5 genotype. As rs1360780 is related to 
antidepressant action and course of disease (Binder et al., 2004; 
Kirchheiner et al., 2008; Lekman et al., 2008), it is possible that 
the remission from the disease might have resulted in changes 
of the FKBP5-dependent stress regulation in these patients. 
In particular, patients carrying the rs1360780 T risk allele are 
known to have a faster response to antidepressant medica-
tion and a stronger cortisol-dependent regulation of FKBP5 
mRNA (Binder et al., 2004), further supporting this assumption. 
Figure 3. CpG methylation rate of FKBP5 intron 7 between groups and FKBP5 genotype. The figure shows estimated means with standard error bars and P-values from 
pairwise comparison of group effects for the TT genotype. MD, lifetime history of major depression. Rs1360780 genotype frequencies: Healthy controls: CC genotype 
n = 27, CT genotype n = 13, TT genotype n = 6; Remitted depression: CC genotype n = 24, CT genotype n = 20, TT genotype n = 6.
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However, it remains unclear as to whether the history of a 
depressive episode or previous antidepressant medication 
might be responsible for the altered effects of FKBP5 on the 
stress regulation. Recent discussions point to an interpreta-
tion of the T allele being the environment-sensitive haplo-
type compared with the CC genotype and therefore, it could 
be influenced more by positive and negative environments 
(Klengel and Binder, 2013). In our study, the increased cortisol 
response of healthy subjects with the TT genotype, which was 
previously shown in other samples (Binder et  al., 2008; Ising 
et al., 2008), vanished in subjects with a lifetime history of MD. 
It seems that episodes of MD or overcoming depression lead to 
a long-lasting change of FKBP5-mediated vulnerability that is 
displayed by a normalized cortisol regulation after psychoso-
cial stress in these subjects.
Changes in the FKBP5 methylation pattern seem to play 
an important role in this context. Klengel et al. (2013) recently 
demonstrated a molecular mechanism of a gene environment 
interaction between childhood trauma and PTSD risk resulting 
from a rs1360780 allele specific demethylation of FKBP5 intron 
7. Demethylation was associated with increased stress-depend-
ent gene transcription followed by a long-term dysregulation 
of the HPA axis, which resulted in a higher risk of developing 
PTSD. In our study, we observed a significant interaction effect 
between the lifetime history of depression and the rs1360780 
genotype with respect to the methylation rate of intron 7 in the 
FKBP5 gene. However, posthoc tests failed to show significant 
group differences, even though a nonsignificant trend toward 
an increased methylation in subjects with the TT genotype who 
remitted from depression was found. A posthoc power analysis 
based on the observed interaction effect revealed a power of .64 
for the current analysis, which falls short of the recommended 
power threshold of .80/.90 (data not shown). Therefore, the fail-
ure to achieve a significant result in the posthoc tests can be 
related to a limited power of the analysis. Nevertheless, the 
suggestive trend corresponds to the observed group effect on 
the plasma cortisol response to psychosocial stress in subjects 
with the TT genotype as well as to a recent report by Yehuda 
et  al. (2013), which found that low FKBP5 methylation in the 
promoter region of the gene is associated with higher corti-
sol levels in a sample of patients with PTSD. Given the limited 
power of the current DNA methylation analysis, these results 
should be considered as preliminary.
A strength of our study is that participants on current 
antidepressant medication were excluded from our analysis. 
Therefore, the gene expression results could not be confounded 
by current antidepressant medication, which is known to be 
associated with FKBP5 gene expression (Wagner et  al., 2012; 
Cattaneo et  al., 2013). However, we do not have reliable infor-
mation about prior antidepressant treatment that could have 
contributed to the diminished genotype-dependent effects in 
remitted depression. Also, childhood trauma could have mod-
ulated the outcome of the study. 13 controls and 14 subjects 
with remitted MD reported childhood adverse events; however, 
only one of them had the TT genotype (data not shown). Thus, 
a separate analysis by genotype × trauma was not suitable for 
our sample. Excluding the case with childhood trauma and TT 
genotype did not influence the significant interaction effects of 
cortisol and FKBP5 mRNA; however, the preliminary analysis 
of DNA methylation failed to show a significant effect (P = .054). 
Therefore, the history of childhood adverse events could have 
influenced in particular the DNA methylation analysis and 
should be included as a factor in future studies. Another limita-
tion is the small sample size, especially of those participants 
with the rs1360780 TT genotype. In particular, results on mRNA 
and DNA methylation should be regarded as exploratory and 
require replication in independent samples. Finally, our study 
followed a strictly hypothesis-driven approach focusing on the 
role of FKBP5 genetics, mRNA expression, and DNA methylation 
of FKBP5 intron 7 as specific functional elements of the HPA axis 
regulation on the psychosocial stress. The genetic analysis was 
restricted to the rs1360780 polymorphism, as a large number of 
studies have described substantial effects of this specific FKBP5 
variant on HPA axis regulation and depression risk. However, 
regarding the absence of FKBP5 effects in remitted depression, 
we cannot exclude that other FKBP5 variants or methylation of 
different regions within the FKBP5 gene might also contribute to 
stress response regulation in these subjects.
In summary, we found evidence of an adaptive negative feed-
back mechanism in healthy controls with the FKBP5 rs1360780 
CC genotype, reflected by a normal cortisol surge after psycho-
social stress accompanied by an FKBP5 mRNA upregulation in 
the expected direction. Healthy controls with the TT genotype, 
however, showed signs of GR resistance as indicated by a steeper 
stress-induced plasma cortisol increase and a slower recovery, cor-
responding to a low methylation rate of the intron 7 region within 
the FKBP5 gene potentially contributing to the observed GR resist-
ance. In remitted depressed individuals, we did not find genotype-
dependent effects of rs1360780 with regard to plasma cortisol 
and FKBP5 mRNA levels after psychosocial stress. It appears that 
previous depression or antidepressant treatment alters the role of 
FKBP5 in stress response regulation, specifically in patients with 
the rs1360780 TT genotype. One could hypothesize that antide-
pressant treatment initiates epigenetic modifications of FKBP5 and 
other stress-related genes (Menke et al., 2012a), which in turn con-
tributes to the well-documented observation of an improved stress 
response regulation after successful depression therapy (Raison 
and Miller, 2003; Ising et  al., 2005; Pariante, 2009). Longitudinal 
studies are warranted to elucidate the dynamics of FKBP5-related 
alterations before, during, and after depression therapy.
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